logo

Search

Login | Create Account

respiratory


Categories

Allergy Asthma COPD Cystic fibrosis End-of-life care ILD Infections Infectious diseases Interventional procedures Lung cancer Medicines Medicopolitical Podcast Public health Research Sleep

Other

Conferences

Specialties


Cardiology Dermatology Endocrinology Gastroenterology Haematology Neurology Oncology Respiratory Rheumatology

General


Contact Us About Us Website Disclaimer Privacy Policy Terms & Conditions

©2022 the limbic

logo

Lockdowns and masks good for childhood asthma, Australian study finds

Lockdowns and mask mandates led to dramatic reductions in paediatric hospital presentations for asthma, Australian-first research has found. Based on figures from two major hospitals in Sydney, the 50-70% falls were likely linked to the overall reduction in viral respiratory infections, the researchers say. There was also evidence that general outdoor air...

Public health

Respiratory physician recognised in Queen’s Birthday Honours

Tuberculosis is a long way from top of the agenda for most Australian clinicians in 2022, which may explain why Professor Guy Marks spends much of his time in Vietnam. On Monday, he was honoured as an Officer of the Order of Australia (AO), for “distinguished service to respiratory medicine and...

Cystic fibrosis

Australian trial backs early azithromycin for kids with CF

Azithromycin failed to reduce structural lung damage in infants with cystic fibrosis (CF) but could still form part of early management strategies given its impact on airway inflammation, exacerbations and hospitalisations, an Australian-led trial suggests. In the phase 3 COMBAT CF study infants aged aged 3-6 months with newly...

Infections

‘Strongly recommended’: new ERS advice on anti-IL-6 mAbs and JAK inhibitors in COVID

Use of IL-6 receptor antagonist monoclonal antibodies (mAb) and JAK inhibitors for the management of COVID-19 in hospitalised patients has received strong backing from the European Respiratory Society (ERS). In the second version of the ERS Living Guideline on...

Use of IL-6 receptor antagonist monoclonal antibodies (mAb) and JAK inhibitors for the management of COVID-19 in hospitalised patients...


Public health

‘Next big health issue after COVID’: NHMRC hardline stance on e-cigs

There is no convincing evidence that electronic cigarettes assist patients to quit and vaping may lead non-smokers to take up tobacco smoking , the NHMRC has warned. The agency released its updated national advice on Thursday, warning that younger people...

There is no convincing evidence that electronic cigarettes assist patients to quit and vaping may lead non-smokers to take up...


Lung cancer

Holy Grail: Restoring anti-tumour immunity in NSCLC

First up: can you describe the aim of your research in 10 words?  To reinvigorate anti-tumour immunity by reprogramming immunosuppressive myeloid cells. A lot of your work involves haematopoietic cell kinase (HCK). Can you tell me what that is, what you’ve learned...

First up: can you describe the aim of your research in 10 words?  To reinvigorate anti-tumour immunity by reprogramming immunosuppressive myeloid...


Cancel